352 related articles for article (PubMed ID: 32415208)
1. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Saatci O; Kaymak A; Raza U; Ersan PG; Akbulut O; Banister CE; Sikirzhytski V; Tokat UM; Aykut G; Ansari SA; Dogan HT; Dogan M; Jandaghi P; Isik A; Gundogdu F; Kosemehmetoglu K; Dizdar O; Aksoy S; Akyol A; Uner A; Buckhaults PJ; Riazalhosseini Y; Sahin O
Nat Commun; 2020 May; 11(1):2416. PubMed ID: 32415208
[TBL] [Abstract][Full Text] [Related]
2. Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.
Assidicky R; Tokat UM; Tarman IO; Saatci O; Ersan PG; Raza U; Ogul H; Riazalhosseini Y; Can T; Sahin O
Breast Cancer Res Treat; 2022 Jun; 193(2):331-348. PubMed ID: 35338412
[TBL] [Abstract][Full Text] [Related]
3. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells.
Zhao Y; Min C; Vora SR; Trackman PC; Sonenshein GE; Kirsch KH
J Biol Chem; 2009 Jan; 284(3):1385-93. PubMed ID: 19029090
[TBL] [Abstract][Full Text] [Related]
4. Integrin α5 down-regulation by miR-205 suppresses triple negative breast cancer stemness and metastasis by inhibiting the Src/Vav2/Rac1 pathway.
Xiao Y; Li Y; Tao H; Humphries B; Li A; Jiang Y; Yang C; Luo R; Wang Z
Cancer Lett; 2018 Oct; 433():199-209. PubMed ID: 29964204
[TBL] [Abstract][Full Text] [Related]
5. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
6. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
[TBL] [Abstract][Full Text] [Related]
7. P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment.
Joo YN; Jin H; Eun SY; Park SW; Chang KC; Kim HJ
Oncotarget; 2014 Oct; 5(19):9322-34. PubMed ID: 25238333
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer.
Cui Y; Huang Y; Wu X; Zheng M; Xia Y; Fu Z; Ge H; Wang S; Xie H
J Cell Physiol; 2019 Jun; 234(6):8740-8751. PubMed ID: 30362543
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis.
Ko YS; Rugira T; Jin H; Joo YN; Kim HJ
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126606
[TBL] [Abstract][Full Text] [Related]
10. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
11. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
12. SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer.
Liu XY; Jiang W; Ma D; Ge LP; Yang YS; Gou ZC; Xu XE; Shao ZM; Jiang YZ
Theranostics; 2020; 10(24):10940-10956. PubMed ID: 33042263
[No Abstract] [Full Text] [Related]
13. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
[TBL] [Abstract][Full Text] [Related]
14. MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC.
Franklin DA; Sharick JT; Ericsson-Gonzalez PI; Sanchez V; Dean PT; Opalenik SR; Cairo S; Judde JG; Lewis MT; Chang JC; Sanders ME; Cook RS; Skala MC; Bordeaux J; Orozco Bender J; Vaupel C; Geiss G; Hinerfeld D; Balko JM
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634121
[TBL] [Abstract][Full Text] [Related]
15. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth.
Pez F; Dayan F; Durivault J; Kaniewski B; Aimond G; Le Provost GS; Deux B; Clézardin P; Sommer P; Pouysségur J; Reynaud C
Cancer Res; 2011 Mar; 71(5):1647-57. PubMed ID: 21239473
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer.
De Vita A; Liverani C; Molinaro R; Martinez JO; Hartman KA; Spadazzi C; Miserocchi G; Taraballi F; Evangelopoulos M; Pieri F; Bongiovanni A; Mercatali L; Tasciotti E; Ibrahim T
Sci Rep; 2021 Mar; 11(1):5107. PubMed ID: 33658580
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts.
Goggins E; Kakkad S; Mironchik Y; Jacob D; Wildes F; Krishnamachary B; Bhujwalla ZM
Neoplasia; 2018 Feb; 20(2):131-139. PubMed ID: 29247885
[TBL] [Abstract][Full Text] [Related]
19. Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC.
Sharma M; Turaga RC; Yuan Y; Satyanarayana G; Mishra F; Bian Z; Liu W; Sun L; Yang J; Liu ZR
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33561195
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway.
Li H; Sun X; Li J; Liu W; Pan G; Mao A; Liu J; Zhang Q; Rao L; Xie X; Sheng X
Neoplasia; 2022 Oct; 32():100821. PubMed ID: 35985176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
